Processa Pharmaceuticals (PCSA) Receivables - Other (2015 - 2025)
Processa Pharmaceuticals' (PCSA) quarterly Receivables - Other came in at $27774.0 in Q1 2025, up 24.58% YoY from $22295.0 in Q1 2024, and up 58993.62% on a QoQ basis from $47.0 in Q4 2024.
Processa Pharmaceuticals (PCSA) Receivables - Other (2015 - 2025) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 10 years of Receivables - Other data on file, last reported at $27774.0 in Q1 2025.
- Quarterly Receivables - Other rose 24.58% year-over-year to $27774.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $27774.0 (up 24.58% YoY) and the FY2024 annual result came in at $47.0, changed N/A from the prior year.
- Receivables - Other climbed to $27774.0 in Q1 2025, from $47.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $27774.0 in Q1 2025 to a low of -$70274.0 in Q1 2022.
- A 4-year average of -$5381.6 and a median of $47.0 in 2024 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2022 — Receivables - Other tumbled 941.1% — and 2025, when it gained 24.58%.
- Tracing PCSA's Receivables - Other over 4 years: stood at -$6750.0 in 2021, then plunged by 941.1% to -$70274.0 in 2022, then surged by 100.07% to $47.0 in 2024, then jumped by 58993.62% to $27774.0 in 2025.
- The last three Receivables - Other figures came in at $27774.0 (Q1 2025), $47.0 (Q4 2024), and $22295.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - |
| 10 | Processa Pharmaceuticals | 5.87 Mn | 5.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 27,774.00 |
| Mar 31, 2025 | 27,774.00 |
| Dec 31, 2024 | 47.00 |
| Dec 31, 2024 | 47.00 |
| Mar 31, 2024 | 22,295.00 |
| Mar 31, 2024 | 22,295.00 |
| Mar 31, 2022 | -70,274.00 |
| Mar 31, 2022 | -70,274.00 |
| Mar 31, 2021 | -6,750.00 |
| Mar 31, 2021 | -6,750.00 |
| Dec 31, 2020 | 154,730.00 |
| Dec 31, 2020 | 154,730.00 |
| Sep 30, 2020 | 7,605.00 |
| Sep 30, 2020 | 7,605.00 |
| Jun 30, 2020 | 26,497.00 |
| Jun 30, 2020 | 26,497.00 |
| Mar 31, 2020 | 27,996.00 |
| Mar 31, 2020 | 27,996.00 |
| Sep 30, 2019 | 663.00 |
| Sep 30, 2019 | 663.00 |